# OnCo record huyabio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/huyabio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "huyabio" ;
  schema:name "HUYABIO International"@en ;
  schema:alternateName "HUYABIO International, LLC."@en, "HUYA Bioscience International"@en, "HUYABIO"@en ;
  schema:description "HUYABIO is a San Diego company that licenses Chinese-discovered medicines for the rest of the world; its lead is tucidinostat, the oral HDAC inhibitor approved in China and Japan for T-cell lymphoma, which it took into a phase 3 trial in melanoma with a checkpoint inhibitor."@en ;
  schema:url <https://onco.cc/companies/huyabio/>, <https://huyabio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://huyabio.com>, <https://clinicaltrials.gov/search?lead=HUYABIO%20International%2C%20LLC.>, <https://www.wikidata.org/wiki/Q140045552> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/tucidinostat/> ;
  onco:companies <https://onco.cc/companies/chipscreen/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct04674683/> .